Kambham John Steeven Wesley

Kambham John Steeven Wesley

Active Director Director DIN 09597527
DIN 09597527 First appointment May 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Kambham John Steeven Wesley

Data last updated:

Kambham John Steeven Wesley is a Director at Genevex Pharma Private Limited (since 2022). The company operates in Healthcare.

DIN 09597527
Primary Designation Director
Industry Healthcare
First Appointment 06 May 2022
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Genevex Pharma Private Limited U74999TG2020PTC142494
Director06 May 20222020Active

Board colleagues of Kambham John Steeven Wesley

Directorship timeline

Open interactive timeline →
Genevex Pharma Private Limited
Premium access

Shareholding and investment profile for Kambham John Steeven Wesley

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kambham John Steeven Wesley

Kambham John Steeven Wesley currently holds 1 directorship: Genevex Pharma Private Limited (Director, since 06 May 2022).

Kambham John Steeven Wesley was first appointed on 06 May 2022 as Director at Genevex Pharma Private Limited.

The current boards of Kambham John Steeven Wesley's companies include Kambham Johnyesu (Genevex Pharma Private Limited), Kambham Suvartha (Genevex Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available